Altered amygdala function in nicotine addiction: Insights from human neuroimaging studies

Neuropsychologia

Volumn 50, Issue 8, 2012, Pages 1719-1729

  Mihov, Yoan ^a   Hurlemann, René ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Abstinence; Addiction; Amygdala; Nicotine; Smoking; Tobacco; Withdrawal

Indexed keywords

NICOTINE;

ABSTINENCE; AMYGDALOID NUCLEUS; ASSOCIATION; BOLD SIGNAL; BRAIN BLOOD FLOW; BRAIN DYSFUNCTION; EMOTION; EXECUTIVE FUNCTION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MEMBRANE STEADY POTENTIAL; NERVE POTENTIAL; NEUROIMAGING; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; REWARD; SATIETY; SENSORY STIMULATION; SMOKING CESSATION; STIMULUS RESPONSE; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

AMYGDALA; BRAIN MAPPING; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; NICOTINE; NICOTINIC AGONISTS; POSITRON-EMISSION TOMOGRAPHY; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 84862883525     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2012.04.028     Document Type: Review

References (135)

1. Adolphs R., Gosselin F., Buchanan T., Tranel D., Schyns P., Damasio A. A mechanism for impaired fear recognition after amygdala damage. Nature 2005, 433:68-72.
2. Adolphs R., Tranel D., Damasio H., Damasio A. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 1994, 372:669-672.
3. Aggleton J., Passingham R. Syndrome produced by lesions of the amygdala in mokeys (Macaca mulatta). Journal of Comparative and Physiological Psychology 1981, 95:961-977.
4. Alderson H., Robbins T., Everitt B. The effects of excitotoxic lesions of the basolateral amygdala on the acquisition of heroin-seeking behavior in rats. Psychopharmacology 2000, 153:111-119.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, American Psychiatric Press, Washington, D.C. 4 edn.
6. Anderson A., Phelps E. Expression without recognition: contributions of the human amygdala to emotional communication. Psychological Science 2000, 11:106-111.
7. Artiges E., Ricales E., Berthoz S., Krebs M., Penttilä J., Trichard C., et al. Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addiction Biology 2009, 14:469-477.
8. Aubin H., Rollema H., Svensson T., Winterer G. Smoking, quitting, and psychiatric disease: a review. Neuroscience and Biobehavaioral Reviews 2011, 10.1016/j.neubiorev.2011.06.007.
9. Becker B., Mihov Y., Scheele D., Kendrick K., Feinstein J., Matusch A., et al. Fear processing and social networking in the absence of a functional amygdala. Biological Psychiatry 2012, 10.1016/j.biopsych.2011.11.024.
10. Bechara A., Damasio A. The somatic marker hypothesis: a neural theory of economic decision. Games and Economic Behavior 2005, 52:336-372.
11. Bechara A., Damsio H., Damasio A., Lee G. Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making. The Journal of Neuroscience 1999, 19:5473-5481.
12. Bechara A., Tranel D., Damasio H., Adolphs R., Rockland C., Damasio A. Double dissociation of conditioning and declarative knowledge relative to the amygdala and hippocampus in humans. Science 1995, 269:1115-1118.
13. Benowitz N. Nicotine addiction. New England Journal of Medicine 2010, 362:2295-2303.
14. Blair H., Sotres-Bayon F., Moita M., Ledoux J. The lateral amygdala processes the value of conditioned and unconditioned aversive stimuli. Neuroscience 2005, 133:561-569.
15. Blanchard D., Blanchard R. Innate and conditioned reactions to threat in rats with amygdaloid lesions. Journal of Comparative and Physiological Psychology 1972, 81:281-290.
16. Brody A. Functional brain imaging of tobacco use and dependence. Journal of Psychiatric Research 2006, 40:404-418.
17. Brody A., Mandelkern M., Olmstead R., Jou J., Tiongson E., Allen V., et al. Neural substrates of resisting craving during cigarette cue exposure. Biological Psychiatry 2007, 62:642-651.
18. Büchel C., Dolan R. Classical fear conditioning in functional neuroimaging. Current Opinion in Neurobiology 2000, 10:219-223.
19. Büchel C., Morris J., Dolan R., Friston K. Brain systems mediating aversive conditioning: an event-related fMRI study. Neuron 1998, 20:947-957.
20. Caggiula A., Donny E., White A., Chaudhri N., Booth S., Gharib M., et al. Cue dependency of nicotine self-administration and smoking. Pharmacology Biochemistry and Behavior 2001, 70:515-530.
21. Cahill L., Babinsky R., Markowitsch H.J., McGaugh J.L. The amygdala and emotional memory. Nature 1995, 377:295-296.
22. Caspi A., Moffitt T., Cannon M., McClay J., Murray R., Harrington H., et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltrasferase gene: longitudinal evidence of a gene x environment interaction. Biological Psychiatry 2005, 57:1117-1127.
23. Chase H., Eickhoff S., Laird A., Hogarth L. The neural basis of drug stimulus processing and craving: an activation likelihood estimation meta-analysis. Biological Psychiatry 2011, 70:785-793.
24. Cheng D., Knight D., Smith C., Stein E., Helmstetter F. Functional mri of human amygdala activity during pavlovian fear conditioning: stimulus processing versus response expression. Behavioural Neuroscience 2003, 117:3-10.
25. Conklin C. Environments as cues to smoke: implications for human extinction-based research and treatment. Experimental and Clinical Psychopharmacology 2006, 14:12-19.
26. Dalley J., Fryer T., Brichard L., Robinson E., Theobald D., Lääne K., et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
27. David S., Munafo M., Johansen-Berg H., Smith S., Rogers R., Matthews P., et al. Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: a functional magnetic resonance imaging study. Biological Psychiatry 2005, 58:488-494.
28. Davis M., Whalen P. The amygdala: vigilance and emotion. Molecular Psychiatry 2001, 6:13-34.
29. De Biasi M., Dani J. Reward, addiction, withdrawal to nicotine. Annual Review of Neuroscience 2011, 34:105-130.
30. De Martino B., Camerer C., Adolphs R. Amygdala damage eliminates monetary loss aversion. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3788-3792.
31. Dolan R. Emotion, cognition, and behavior. Science 2002, 298:1191-1194.
32. Dome P., Lazary J., Kalapos M., Rihmer Z. Smoking, nicotine and neuropsychiatric disorders. Neuroscience & Biobehavioral Reviews 2010, 34:295-342.
33. Domino E., Minoshima S., Guthrie S., Ohl L., Ni L., Koeppe R., et al. Effects of nicotine on regional cerebral glucose metabolism in awake resting state tobacoo smokers. Neuroscience 2000, 101:277-282.
34. Domino E., Minoshima S., Guthrie S., Ohl L., Ni L., Koeppe R., et al. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse 2000, 38:313-321.
35. Domino E., Ni L., Xu Y., Koeppe R., Guthrie S., Zubieta J. Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarettes. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004, 28:319-327.
36. Due D., Huettel S., Hall W., Rubin D. Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: evidence from functional magnetic resonance imaging. American Journal of Psychiatry 2002, 159:954-960.
37. Durazzo T., Meyerhoff D., Nixon S. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. International Journal of Environmental Research and Public Health 2010, 7:3760-3791.
38. Engelmann J., Versace F., Robinson J., Minnix J., Lam C., Cui Y., et al. Neural substrates of smoking cue reactivity: A meta-analysis of fMRI studies. Neuroimage 2011, 60:252-262.
39. Etter J., Hughes J. A comparison of the psychometrics of three cigarette withdrawal scales. Addiction 2006, 101:363-372.
40. Evans D., Drobes D. Nicotine self-medication of cognitive-attentional processing. Addiction Biology 2008, 14:32-42.
41. Everitt B., Robbins T. Central cholinergic systems and cognition. Annual Reviews of Psychology 1997, 48:649-684.
42. Everitt B., Robbins T. Neurla systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neuroscience 2005, 8:1481-1489.
43. Fagerström K. Measuring degree of physical dependency to tobacco smoking with reference to individualization of treatment. Addictive Behaviors 1978, 3:235-241.
44. Feinstein J., Adolphs R., Damasio A., Tranel D. The human amygdala and the induction and experience of fear. Current Biology 2011, 21:34-38.
45. Field M., Santarcangelo M., Sumnall H., Goudie A., Cole J. Delay discounting and the behavioural economics of cigarette purchases in smokers: the effects of nicotine deprivation. Psychopharmacology 2006, 186:255-263.
46. Fiore, M., Jaen, C., Baker, T., Bailey, W., Benowitz, N., Curry, S., et al. (2008). Treating tobacco use and dependence: 2008 update.
47. Fowler J., Volkow N., Wang G., Pappas N., Logan J., MacGregor R., et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996, 379:733-736.
48. Fowler J., Volkow N., Wang G., Pappas N., Logan J., Shea C., et al. Brain monoamine oxidase A inhibition in cigarette smokers. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:14065-14069.
49. Franklin T., Wang Z., Wang J., Sciortino N., Harper D., Li Y., et al. Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology 2007, 32:2310-2319.
50. Gale G., Anagnostaras S., Godsil B., Mitchell S., Nozawa T., Sage J., et al. Role of the basolateral amygdala in the storage of fear memories across the adult lifetime of rats. Journal of Neuroscience 2004, 24:3810-3815.
51. Gallagher M., Holland P. The amygdala complex: multiple roles in associative learning and attention. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:11771-11776.
52. Goossens L., Kukolja J., Onur O.A., Fink G.R., Maier W., Griez E., et al. Selective processing of social stimuli in the superficial amygdala. Human Brain Mapping 2009, 30:3332-3338.
53. Gospic K., Mohlin E., Fransson P., Petrovic P., Johanesson M., Ingvar M. Limbic justice-amygdala involvement in immediate rejection in the ultimatum game. PLoS Biology 2011, 9:e1001054.
54. Hamann S. Cognitive and neural mechanisms of emotional memory. Trends in Cognitive Sciences 2001, 5:394-400.
55. Hamidovic A., Dlugos A., Skol A., Palmer A., de Wit H. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Experimental and Clinical Psychopharmacology 2009, 17(6):374-383.
56. Hartwell K., Johnson K., Li X., Myrick H., LeMatty T., George M., et al. Neural correlates of craving and resisting craving for tobacco in nicotine dependent subjects. Addiction Biology 2011, 16(4):654-666.
57. Heatherton T., Kozlowski L., Frecker R., Fagerström K. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 1991, 86:1119-1127.
58. Heishman S., Kleykamp B., Singleton E. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology 2010, 210:453-469.
59. Heishman S., Taylor R., Henningfield J. Nicotine and smoking: a review of effects on human performance. Experimental and Clinical Psychopharmacology 1994, 2:345-395.
60. Holland P., Gallagher M. Amygdala circuitry in attentional and representational processes. Trends in Cognitive Sciences 1999, 3:65-73.
61. Hughes J. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine & Tobacco Research 2007, 9:315-327.
62. Hughes J., Hatsukami D. Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry 1986, 43:289-294.
63. Hurlemann R., Wagner M., Hawellek B., Reich H., Pieperhoff P., Amunts K., et al. Amygdala control of emotion-induced forgetting and remembering. Neuropsychologia 2007, 45:877-884.
64. Janes A., Frederick B., Richardt S., Burbridge C., Merlo-Pich E., Renshaw P., et al. Experimental and Clinical Psychopharmacology 2009, 17:365-373.
65. Janes A., Pizzagalli D., Richardt S., Frederick B., Chuzi S., Pachas G., et al. Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biological Psychiatry 2010, 67:722-729.
66. Jasinska A., Chua H., Ho S., Polk T., Rozek L., Strecher V. Amygdala response to smoking-cessation messages mediates the effects of serotonin transposter gene variation on quitting. NeuroImage 2012, 60:766-773.
67. Kalin N., Shelton S., Davidson R., Kelley A. The primate amygdala mediates acute fear but not the behavioral and physiological components of anxious temperament. The Journal of Neuroscience 2001, 21:2067-2074.
68. Kalivas P., McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology 2003, 168:44-56.
69. Kapp B., Whalen P., Supple W., Pascoe J. Amygdaloid contributions to conditioned arousal and sensory information processing. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction (229-254) 1992, Wiley-Liss, New York. Aggleton (Ed.).
70. Kenny P., Markou A. Neurobiology of the nicotine withdrawal syndrome. Pharmacology, Biochemistry and Behavior 2001, 70:531-549.
71. Killen J.D., Fortmann S.P. Craving is associated with smoking relapse: findings from three prospective studies. Experimental and Clinical Psychopharmacology 1997, 5:137-142.
72. Kluver H., Bucy P. Preliminary analysis of functions of the temporal lobe in monkeys. Archives of Neurology and Psychiatry 1939, 42:979-1000.
73. Knight D., Smith C., Cheng D., Stein E., Helmstetter F. Amygdala and hippocampal activity during acquisition and extinction of human fear conditioning. Cognitive, Affective & Behavioural Neuroscience 2004, 4:317-325.
74. Kober H., Mende-Siedlecki P., Kross E., Weber J., Mischel W., Hart C., et al. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:14811-14816.
75. Kobiella A., Ulshöfer D., Vollmert C., Vollstädt-Klein S., Bühler M., Esslinger C., et al. Nicotine increases neural responses to unpleasant stimuli and anxiety in non-smokers. Addiction Biology 2010, 16:285-295.
76. Kühn S., Gallinat J. Common biology of craving across legal and illegal drugs-a quantitative meta-analysis of cue-reactivitiy brain response. European Journal of Neuroscience 2011, 33:1318-1326.
77. Kumari V., Postma P. Nicotine use in schizophrenia: the self medication hypotheses. Neuroscience & Biobehavioral Reviews 2005, 29:1021-1034.
78. LaBar K., Gatenby J., Gore J., LeDoux J., Phelps E. Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 1998, 20:937-945.
79. LaBar K., LeDoux J., Spencer D., Phelps E. Impaired fear conditioning following unilateral temporal lobectomy in humans. Journal of Neuroscience 1995, 15:6846-6855.
80. LeDoux J. Emotion circuits in the brain. Annual Review of Neuroscience 2000, 23:155-184.
81. LeDoux J. The amygdala. Current Biology 2007, 17:868-874.
82. Lee J., Lim Y., Wiederhold B., Graham S. A functional magnetic resonance imaging (fMRI) study of cue-induced smoking craving in virtual environments. Applied Psychophysiology and Biofeedback 2005, 30:195-204.
83. Ludwig V., Mihov Y., Schwarting R. Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior. Behavioural Brain Research 2008, 189:52-64.
84. Luijten M., Veltman D., Brink W., Hester R., Field M., Smits M., et al. Neurobiological substrate of smoking-related attentional bias. NeuroImage 2011, 54:2374-2381.
85. Malecki R., Zdrojowy K., Adamiec R. Thromboangiitis obliterans in the 21st century-a new face of disease. Atherosclerosis 2009, 206:328-334.
86. McBride D., Barrett S., Kelly J., Aw A., Dagher A. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI studies. Neuropsychopharmacology 2006, 31:2728-2738.
87. McClernon J., Gilbert D. Human functional neuroimaging in nicotine and tobacco research: Basics, background, and beyond. Nicotine & Tobacco Research 2004, 6:941-959.
88. McClernon J., Hiott B., Huettel S., Rose J. Abstinence-induced changes in self-report craving correlate with event-related fMRI responses to smoking cues. Neuropsychopharmacology 2005, 30:1940-1947.
89. McClernon J., Hiott B., Liu J., Salley A., Behm F., Rose J. Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation: results of a preliminary functional magnetic resonance imaging. Addiction Biology 2007, 12:503-512.
90. McClernon F., Kozink R., Rose J. Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacology 2008, 33:2148-2157.
91. Mitchell S. Effects of short-term nicotine deprivation on decision-making: delay, uncertainty and effort discounting. Nicotine and Tobacco Research 2004, 6:819-828.
92. Nestor L., McCabe E., Jones J., Clancy L., Garavan H. Differences in "bottom-up" and "top-down" neural activity in current and former cigarette smokers: evidence for neural substrates which may promote nicotine abstinence through increased cognitive control. NeuroImage 2011, 56:2258-2275.
93. Newhouse P., Potter A., Singh A. Effects of nicotinic stimulation on cognitive performance. Current Opinion in Pharmacology 2004, 4:36-46.
94. Newhouse P., Singh A., Potter A. Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. Current Topics in Medical Chemistry 2004, 4:267-282.
95. Ohmura Y., Takahashi T., Kitamura N. Discounting delayed and probabilistic monetary gains and losses by smokers of cigarettes. Psychopharmacology 2005, 182:508-515.
96. Okuyemi K., Powell J., Savage C., Hall S., Nollen N., Holsen L., et al. Enhanced cue-elicited brain activation in African American compared with Caucasian smokers: an fMRI study. Addiction Biology 2006, 11:97-106.
97. Olsson A., Nearing K.I., Phelps E.A. Learning fears by observing others: the neural systems of social fear transmission. Social Cognitive and Affective Neuroscience 2007, 2:3-11.
98. Onur O., Patin A., Mihov Y., Buecher B., Stoffel-Wagner B., Schlaepfer T., et al. Overnight deprivation from smoking disrupts amygdala responses to fear. Human Brain Mapping 2012, 33:1407-1416.
99. Paton J., Belova M., Morrison S., Salzman D. The primate amygdala represents the positive and negative value of visual stimuli during learning. Nature 2006, 439:865-870.
100. Phelps E. Emotion and cognition: insights from studies of the human amygdala. Annual Review of Psychology 2006, 57:27-53.
101. Phelps E., Anderson A. Emotional memory: what does the amygdala do?. Current Biology 1997, 7:R311-R320.
102. Reardon S. Antismoking drive tries cigarette ads, in reverse. Science 2011, 333:23-24.
103. Retey J.V., Adam M., Khatami R., Luhmann U., Jung H., Berger W., et al. A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clinical Pharmacology and Therapeutics 2007, 81:692-698.
104. Reuter M., Netter P., Rogausch A., Sander P., Kaltschmidt M., Dörr A., et al. The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects. Human Psychopharmacology: Clinical and Experimental 2002, 17:213-224.
105. Robinson T., Berridge K. Incentive-sensitization and addiction. Addiction 2001, 96:103-114.
106. Rose J., Behm F., Salley A., Bates J., Coleman R., Hawk T., et al. Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology 2007, 32:2441-2452.
107. Rose J., Behm F., Westman E., Mathew R., London E., Hawk T., et al. PET studies of the influences of nicotine on neural systems in cigarette smokers. American Journal of Psychiatry 2003, 160:323-333.
108. Rosen J., Donley M. Animal studies of amygdala function on fear and uncertainty: relevance to human research. Biological Psychology 2006, 73:49-60.
109. Rubinstein M., Luks T., Moscicki A., Dryden W., Rait M., Simpson G. Smoking-related cue-induced brain activation in adolescent light smokers. Journal of Adolescent Health 2011, 48:7-12.
110. Schaefer A., Braver T., Reynolds J., Burgess G., Yarkoni T., Gray J. Individual differences in amygdala activity predict response speed during working memory. The Journal of Neuroscience 2006, 26:10120-10128.
111. Schaefer A., Gray J. A role for the human amygdala in higher cognition. Reviews in Neurosciences 2007, 18:355-382.
112. Scheele, D., Mihov, Y., Kendrick, K., Feinstein, J., Reich, J., Maier, W. (2012). Amygdala lesion profoundly alters altruistic punishment. Biological Psychiatry 10.1016/j.biopsych.2012.01.028.
113. Schiffmann S., Paty J.A., Gwaltney C.J., Dang Q. Immediate antecedents of cigarette smoking: an analysis of unrestricted smoking patterns. Journal of Abnormal Psychology 2004, 113:166-171.
114. Schneider N., Jarvik M. Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology 1984, 82:143-144.
115. Schumacher A., Mössner R., Quednow B., Kühn K., Wagner M., Cvetanovska G., et al. Influence of 5-HT3 receptor subunit genes HTR3A, HTR3B, HTR3C, HTR3D and HTR3E on treatment response to antipsychotics in schizophrenia. Pharmacogenetics and Genomics 2009, 19:843-851.
116. Seymour B., Dolan R. Emotion, decision making, and the amygdala. Neuron 2008, 58:662-671.
117. Shaham Y., Shalev U., Lu L., de Wit H., Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology 2003, 168:3-20.
118. Shiffman S., Jarvik M. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 1976, 50:35-39.
119. Stead L., Perera R., Bullen C., Mant D., Lancaster T. Nicotine replacement therapy for smoking cessation. from Cochrane Database Syst Rev 2008, 1.
120. Stippekohl B., Winkler M., Mucha R., Pauli P., Walter B., Vaitl D., et al. Neural responses to BEGIN- and END-stimuli of the smoking ritual in nonsmokers, nondeprived smokers, and deprived smokers. Neuropsychopharmacology 2010, 35:1209-1225.
121. Strange B., Hurlemann R., Dolan R. An emotion-induced retrograde amnesia in humans is amygdala- and Β-adrenergic-dependent. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:13626-13631.
122. Swan G., Lessov-Schlaggar C. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychology Review 2007, 17:259-273.
123. Tiffany S., Drobes D. The development and initial validation of a questionnaire on smoking urges. British Journal of Addiction 1991, 86:1467-1476.
124. U.S.Department of Health and Human Services How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. A Report of the Surgeon General 2010, Rockville, MD.
125. Wang Z., Faith M., Patterson F., Tang K., Kerrin K., Wileyto E., et al. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. The Journal of Neuroscience 2007, 27:14035-14040.
126. Weiskrantz L. Behavioral changes associated with ablation of the amygdaloid complex in mokeys. Journal of Comparative and Physiological Psychology 1956, 49:381-391.
127. Welsch S., Smith S., Wetter D., Jorenby D., Fiore M., Baker T. Development and validation of the Wisconsin Smoking Withdrawal Scale. Experimental and Clinical Psychopharmacology 1999, 7:354-361.
128. West R., Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology 2004, 177:195-199.
129. Whalen P. Fear, vigilance, and ambiguity: initial neuroimaging studies of the human amygdala. Current Directions in Psychological Science 1998, 7:177-188.
130. Whitelaw R., Markou A., Robbins T., Everitt B. Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology 1996, 127:213-224.
131. Wilson N. Smokers respond to pictorial health warnings. Science 2011, 333:822.
132. Wilson S., Sayette M., Delgado M., Fiez J. Instructed smoking expectancy modulates cue-elicited neural activity: a preliminary study. Nicotine & Tobacco research 2005, 7:637-645.
133. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research 1993, World Health Organization, Geneva, Switzerland.
134. Zubieta J., Heitzeg M., Yanjun X., Koeppe R., Lisong N., Guthrie S., et al. Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. American Journal of Psychiatry 2005, 162:567-577.
135. Zubieta J., Lombardi U., Minoshima S., Guthrie S., Ni L., Ohl L., et al. Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biological Psychiatry 2001, 49:906-913.